ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 263434 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 263434; 2) Community: the network communities that were significantly associated with the response to NSC 263434; 3) Molecule: the relationships between components within communities and NSC 263434; 4) MDR: the compounds that were significantly associated with the NSC 263434.

NSC Compound Enrichment Correlation
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.43448075
NSC 606497 Camptothecin Derivative 0.0297837393005856 0.19126774
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.0297837393005856 0.10963263
NSC 660313 Null 0.0297837393005856 0.36907557
NSC 67091 Null 0.0297837393005856 0.21737883
NSC 672974 Null 0.0297837393005856 0.19837058
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0297837393005856 0.02579081
NSC 684144 Null 0.0297837393005856 0.24433291
NSC 693135 Null 0.0297837393005856 0.11722353
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0297837393005856 0.11960971
Total:64  Current:37    [First] [Prev] [Next] [Last]